STOCK TITAN

[Form 4] Columbia Financial, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Columbia Financial (CLBK) reported an insider transaction by its President & CEO (also a Director). On 10/17/2025, the executive acquired 130.1624 common stock units at $13.73 through the Bank’s Stock‑Based Deferral Plan.

Per the plan, these are phantom stock interests that will be settled in shares upon distribution to the reporting person. Following this transaction, 65,921.0746 units were beneficially owned under the deferral plan.

The filing also lists outstanding stock options, including 656,471 options at an exercise price of $15.60 expiring on 07/23/2029, and additional grants of 37,894 at $15.94 (exp. 05/01/2033), 37,168 at $16.49 (exp. 03/06/2034), and 94,749 at $16.23 (exp. 03/03/2035).

Columbia Financial (CLBK) ha riportato una transazione interna da parte del Presidente e CEO (anche Direttore). Il 17/10/2025, l'esecutivo ha acquistato 130.1624 unità di azioni comuni a $13.73 tramite il Piano di Differimento Basato su Azioni della Banca.

Secondo il piano, si tratta di interessi azionari fantasma che saranno regolati in azioni al momento della distribuzione alla persona che segnala. Dopo questa transazione, 65.921,0746 unità erano detenute in modo beneficiario ai sensi del piano di differimento.

La documentazione elenca anche stock option in essere, tra cui 656.471 opzioni a un prezzo di esercizio di $15,60 con scadenza il 23/07/2029, e ulteriori concessioni di 37.894 a $15,94 (scadenza 01/05/2033), 37.168 a $16,49 (scadenza 06/03/2034), e 94.749 a $16,23 (scadenza 03/03/2035).

Columbia Financial (CLBK) informó una operación interna por parte de su Presidente y CEO (también Director). El 17/10/2025, el ejecutivo adquirió 130.1624 unidades de acciones comunes por $13.73 a través del Plan de Diferimiento Basado en Acciones del Banco.

Según el plan, se trata de intereses de acciones fantasma que se liquidarán en acciones en el momento de la distribución a la persona que reporta. Después de esta transacción, 65.921,0746 unidades eran poseídas beneficiosamente bajo el plan de diferimiento.

La presentación también enumera opciones de acciones pendientes, incluyendo 656.471 opciones a un precio de ejercicio de $15.60 con vencimiento el 23/07/2029, y adjudicaciones adicionales de 37.894 a $15.94 (venc. 01/05/2033), 37.168 a $16.49 (venc. 06/03/2034) y 94.749 a $16.23 (venc. 03/03/2035).

Columbia Financial (CLBK)는 사장 겸 CEO(이사이기도 한)의 내부 거래를 보고했습니다. 2025년 10월 17일에 경영진은 은행의 주식 기반 이연 계획을 통해 130.1624 주식의 일반주 단위를 $13.73에 취득했습니다.

계획에 따르면 이는 주식 фан텀 이익으로, 보고자에게 분배될 때 주식으로 현금화될 예정입니다. 이 거래 이후 65,921.0746 주가 이연 계획에 따라 유익하게 보유되고 있습니다.

공시에는 남은 주식 옵션도 포함되어 있으며, 행사 가격이 $15.60이고 만료일이 2029-07-23656,471 옵션과, 추가로 37,894개가 $15.94(만료 2033-05-01), 37,168개가 $16.49(만료 2034-03-06), 94,749개가 $16.23(만료 2035-03-03)입니다.

Columbia Financial (CLBK) a publié une opération interne impliquant son Président-directeur général (également administrateur). Le 17/10/2025, l’exécutif a acheté 130,1624 actions ordinaires à $13,73 via le Plan de Report Basé sur les Actions de la Banque.

Selon le plan, il s’agit d’intérêts d’actions fantômes qui seront réglés en actions lors de la distribution à la personne qui signale. Après cette opération, 65,921,0746 actions étaient détenues de manière bénéficiaire dans le cadre du plan de report.

Le dossier énumère également des options d’achat en circulation, y compris 656,471 options à un prix d’exercice de $15,60 exp. le 23/07/2029, et des attributions supplémentaires de 37,894 à 15,94 $ (exp. 01/05/2033), 37,168 à 16,49 $ (exp. 06/03/2034), et 94,749 à 16,23 $ (exp. 03/03/2035).

Columbia Financial (CLBK) meldete eine Insider-Transaktion seines Präsidenten & CEO (auch Director). Am 17.10.2025 erwarb der Geschäftsführer 130,1624 Stammaktieneinheiten zu $13,73 über den Aktien-basierten Tilgungsplan der Bank.

Nach dem Plan handelt es sich um Phantomaktieninteressen, die bei Ausschüttung an die meldende Person in Aktien erledigt werden. Nach dieser Transaktion waren 65.921,0746 Einheiten gemäß dem Tilgungsplan beneficial ownership.

Die Einreichung listet auch ausstehende Aktienoptionen auf, darunter 656.471 Optionen zu einem Ausübungspreis von $15,60 mit Ablauf am 23.07.2029, sowie zusätzliche Zuwendungen von 37.894 bei $15,94 (Ablauf 01.05.2033), 37.168 bei $16,49 (Ablauf 06.03.2034) und 94.749 bei $16,23 (Ablauf 03.03.2035).

Columbia Financial (CLBK) أبلغت عن صفقة داخلية من قبل الرئيس التنفيذي (أيضاً مدير). في 17/10/2025، اشترى التنفيذي 130.1624 وحدة من الأسهم العادية بقيمة $13.73 من خلال خطة التأجيل المعتمدة على الأسهم للبنك.

وفقاً للخطة، هذه حقوق أسهم خيالية ستُ settled في أسهم عند التوزيع على الشخص المبلِغ. بعد هذه الصفقة، كانت 65,921.0746 وحدة مملوكة بشكل استحقاق بموجب خطة التأجيل.

إشعار الملف يتضمن أيضاً خيارات أسهم قائمة، بما في ذلك 656,471 خياراً بسعر تنفيذ $15.60 تنتهي صلاحيتها في 23/07/2029، و منح إضافية من 37,894 بسعر 15.94 دولار (انتهاء 01/05/2033)، و 37,168 بسعر 16.49 دولار (انتهاء 06/03/2034)، و 94,749 بسعر 16.23 دولار (انتهاء 03/03/2035).

Columbia Financial (CLBK) 报告了其总裁兼首席执行官(也是董事)的一笔内部交易。在2025-10-17,该高管通过银行的基于股票的递延计划购买了130.1624单位普通股,价格为$13.73

根据该计划,这些是虚拟股票权益,分配给报告人时将以股票结算。此次交易后,在递延计划下,65,921.0746单位被受益持有。

filing 还列出了未行使的股票期权,其中包含656,471份,行使价为$15.60,到期日为2029-07-23,以及额外的授予:37,894份,$15.94(到期日2033-05-01),37,168份,$16.49(到期日2034-03-06),94,749份,$16.23(到期日2035-03-03)。

Positive
  • None.
Negative
  • None.

Columbia Financial (CLBK) ha riportato una transazione interna da parte del Presidente e CEO (anche Direttore). Il 17/10/2025, l'esecutivo ha acquistato 130.1624 unità di azioni comuni a $13.73 tramite il Piano di Differimento Basato su Azioni della Banca.

Secondo il piano, si tratta di interessi azionari fantasma che saranno regolati in azioni al momento della distribuzione alla persona che segnala. Dopo questa transazione, 65.921,0746 unità erano detenute in modo beneficiario ai sensi del piano di differimento.

La documentazione elenca anche stock option in essere, tra cui 656.471 opzioni a un prezzo di esercizio di $15,60 con scadenza il 23/07/2029, e ulteriori concessioni di 37.894 a $15,94 (scadenza 01/05/2033), 37.168 a $16,49 (scadenza 06/03/2034), e 94.749 a $16,23 (scadenza 03/03/2035).

Columbia Financial (CLBK) informó una operación interna por parte de su Presidente y CEO (también Director). El 17/10/2025, el ejecutivo adquirió 130.1624 unidades de acciones comunes por $13.73 a través del Plan de Diferimiento Basado en Acciones del Banco.

Según el plan, se trata de intereses de acciones fantasma que se liquidarán en acciones en el momento de la distribución a la persona que reporta. Después de esta transacción, 65.921,0746 unidades eran poseídas beneficiosamente bajo el plan de diferimiento.

La presentación también enumera opciones de acciones pendientes, incluyendo 656.471 opciones a un precio de ejercicio de $15.60 con vencimiento el 23/07/2029, y adjudicaciones adicionales de 37.894 a $15.94 (venc. 01/05/2033), 37.168 a $16.49 (venc. 06/03/2034) y 94.749 a $16.23 (venc. 03/03/2035).

Columbia Financial (CLBK)는 사장 겸 CEO(이사이기도 한)의 내부 거래를 보고했습니다. 2025년 10월 17일에 경영진은 은행의 주식 기반 이연 계획을 통해 130.1624 주식의 일반주 단위를 $13.73에 취득했습니다.

계획에 따르면 이는 주식 фан텀 이익으로, 보고자에게 분배될 때 주식으로 현금화될 예정입니다. 이 거래 이후 65,921.0746 주가 이연 계획에 따라 유익하게 보유되고 있습니다.

공시에는 남은 주식 옵션도 포함되어 있으며, 행사 가격이 $15.60이고 만료일이 2029-07-23656,471 옵션과, 추가로 37,894개가 $15.94(만료 2033-05-01), 37,168개가 $16.49(만료 2034-03-06), 94,749개가 $16.23(만료 2035-03-03)입니다.

Columbia Financial (CLBK) a publié une opération interne impliquant son Président-directeur général (également administrateur). Le 17/10/2025, l’exécutif a acheté 130,1624 actions ordinaires à $13,73 via le Plan de Report Basé sur les Actions de la Banque.

Selon le plan, il s’agit d’intérêts d’actions fantômes qui seront réglés en actions lors de la distribution à la personne qui signale. Après cette opération, 65,921,0746 actions étaient détenues de manière bénéficiaire dans le cadre du plan de report.

Le dossier énumère également des options d’achat en circulation, y compris 656,471 options à un prix d’exercice de $15,60 exp. le 23/07/2029, et des attributions supplémentaires de 37,894 à 15,94 $ (exp. 01/05/2033), 37,168 à 16,49 $ (exp. 06/03/2034), et 94,749 à 16,23 $ (exp. 03/03/2035).

Columbia Financial (CLBK) meldete eine Insider-Transaktion seines Präsidenten & CEO (auch Director). Am 17.10.2025 erwarb der Geschäftsführer 130,1624 Stammaktieneinheiten zu $13,73 über den Aktien-basierten Tilgungsplan der Bank.

Nach dem Plan handelt es sich um Phantomaktieninteressen, die bei Ausschüttung an die meldende Person in Aktien erledigt werden. Nach dieser Transaktion waren 65.921,0746 Einheiten gemäß dem Tilgungsplan beneficial ownership.

Die Einreichung listet auch ausstehende Aktienoptionen auf, darunter 656.471 Optionen zu einem Ausübungspreis von $15,60 mit Ablauf am 23.07.2029, sowie zusätzliche Zuwendungen von 37.894 bei $15,94 (Ablauf 01.05.2033), 37.168 bei $16,49 (Ablauf 06.03.2034) und 94.749 bei $16,23 (Ablauf 03.03.2035).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kemly Thomas J.

(Last) (First) (Middle)
19-01 ROUTE 208 NORTH

(Street)
FAIR LAWN NJ 07410

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Columbia Financial, Inc. [ CLBK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/17/2025 A 130.1624(1) A $13.73 65,921.0746 I By Stock-Based Deferral Plan
Common Stock 233,808 D
Common Stock 40,946 I By 401(k)
Common Stock 7,620 I By ESOP
Common Stock 32,597 I By SERP
Common Stock 41,572 I By SIM
Common Stock 5,933 I By Spouse
Common Stock 43,411 I By Stock Award II(2)
Common Stock 50,686 I By Stock Award III(3)
Common Stock 54,690 I By Stock Award IV(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $15.6 07/23/2020(5) 07/23/2029 Common Stock 656,471 656,471 D
Stock Options (right to buy) $15.94 05/01/2024(6) 05/01/2033 Common Stock 37,894 37,894 D
Stock Options (right to buy) $16.49 03/06/2025(7) 03/06/2034 Common Stock 37,168 37,168 D
Stock Options (right to buy) $16.23 03/03/2026(8) 03/03/2035 Common Stock 94,749 94,749 D
Explanation of Responses:
1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on May 1, 2024; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
3. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
4. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
5. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
6. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on May 1, 2024.
7. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
8. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
Remarks:
/s/ Dennis E. Gibney, Power of Attorney 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Columbia Financ

NASDAQ:CLBK

CLBK Rankings

CLBK Latest News

CLBK Latest SEC Filings

CLBK Stock Data

1.49B
26.84M
74.42%
13.11%
1.5%
Banks - Regional
Savings Institution, Federally Chartered
Link
United States
FAIR LAWN